Human OX40/TNFRSF4 Antibody

Catalog #: MAB10545 Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
MAB10545-100
MAB10545-SP

Detection of OX40/TNFRSF4 in Human PBMCs by Flow Cytometry.

1 Image

All OX40/TNFRSF4 Antibodies

Product Details

Supplemental Products

Reviews

Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human OX40/TNFRSF4 Antibody Summary

Species Reactivity

Human

Specificity

Detects human OX40/TNFRSF4 in direct ELISAs.

Source

Monoclonal Mouse IgG_2B Clone # 2553B

Purification

Protein A or G purified from cell culture supernatant

Immunogen

Mouse myeloma cell line, NS0-derived human OX40/TNFRSF4
Leu29-Ala216
Accession # P43489

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Label

Unconjugated

Applications

Recommended Concentration

Sample

Flow Cytometry

0.25 µg/10⁶ cells

See below

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Flow Cytometry

View Larger

Detection of OX40/TNFRSF4 in Human PBMCs by Flow Cytometry. Human peripheral blood mononuclear cells (PBMCs) were stained with Mouse Anti-Human CD3 epsilon PE-conjugated Monoclonal Antibody (Catalog # FAB100P) and either (A) Rabit Anti-Human OX40/TNFRSF4 Monoclonal Antibody (Catalog # MAB10545) or (B) Rabbit IgG Isotype Control (Catalog # MAB1050) followed by APC-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # F0111). View our protocol for Staining Membrane-associated Proteins.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: OX40/TNFRSF4

OX40 (CD134; TNFRSF4) is a T cell co-stimulatory molecule of the TNF receptor superfamily that coordinates with other co-stimulators (CD28, CD40, CD30, CD27 and 4-1BB) to manage the activation of the immune response (1-3). Human OX40 is a 48 kDa type I transmembrane glycoprotein with a 28 amino acid (aa) signal sequence, a 185 aa extracellular domain (ECD) that contains a cysteine-rich region, a 20 aa transmembrane segment, and a 41 aa cytoplasmic domain (4). The ECD of human OX40 shares 63% sequence identity with the ECD of mouse and rat OX40. OX40 is up-regulated on CD4⁺ and CD8⁺ T cells upon engagement of the TCR by antigen presenting cells along with co-stimulation by CD40-CD40 Ligand and CD28-B7 (5, 6). OX40 Ligand is primarily expressed on antigen presenting cells (5). OX40 Ligand engagement of OX40 on activated CD4⁺ T cells results in increased T cell survival, proliferation, and cytokine production. It also inhibits the conversion of effector T cells into immunosuppressive regulatory T cells (Tregs) and can promote the maintenance of and recall response in memory T cells (3, 7-10). OX40 is constitutively expressed on Tregs and enhances the sensitivity of Tregs to IL-2, thus promoting Treg proliferation. OX40 has also been shown to decrease the cells’ immunosuppressive activity on effector T cells (11-14). OX40-OX40 Ligand signaling is involved in allergic airway inflammation, graft-versus-host disease and autoimmune disease (6, 15, 16). Mutations in OX40 and OX40 Ligand are associated with cardiovascular disease (17, 18).

References

Hori, T. (2006) Int. J. Hematol. 83:17.
Latza, U. et al. (1994) Eur. J. Immunol. 24:677.
Salek-Ardakani, S. et al. (2003) J. Exp. Med. 198:315.
al-Shamkhani, A. et al. (1996) Eur. J. Immunol. 26:1695.
Moran, A.E. et al. (2013) Curr. Opin. Immunol. 25:230.
Gramaglia, I. et al. (1998) J. Immunol. 161:6510.
Xiao, X. et al. (2008) J. Immunol. 181:3193.
So, T. and M. Croft (2007) J. Immunol. 179:1427.
Mousavi, S.F. et al. (2008) J. Immunol. 181:5990.
Bansal-Pakala, P. et al. (2001) Nat. Med. 7:907.
Piconese, S. et al. (2010) Eur. J. Immunol. 40:2902.
Griseri, T. et al. (2010) J. Exp. Med. 207:699.
Xiao, X. et al. (2012) J. Immunol. 188:892.
Vu, M.D. et al. (2007) Blood 110:2501.
Damayanti, T. et al. (2010) Am. J. Respir. Crit. Care Med. 181:688.
Xiao, X. et al. (2012) Nat. Immunol. 13:981.
Nakano, M. et al. (2010) Cardiovasc. Res. 88:539.
Ishii, N. et al. (2010) Adv. Immunol. 105:63.
Godfrey, W.R. et al. (1994) J. Exp. Med. 180:757

Entrez Gene IDs

7293 (Human); 22163 (Mouse); 25572 (Rat); 102145978 (Cynomolgus Monkey)

Alternate Names

ACT-135; ACT35 antigen; ACT35ATC35 antigen; CD134 antigen; CD134; Ly-70; OX40 cell surface antigen; OX40 homologue; OX40; OX40L receptor; OX40lymphoid activation antigene ACT35; TAX transcriptionally-activated glycoprotein 1 receptor; tax-transcriptionally activated glycoprotein 1 receptor; TNFRSF4; tumor necrosis factor receptor superfamily member 4; tumor necrosis factor receptor superfamily, member 4; Txgp1; TXGP1L; TXGP1LOX40 antigen